electroCore Presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference
30 Setembro 2021 - 10:05AM
electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a
commercial-stage bioelectronic medicine company, today announced
that its presentation at the Cantor Fitzgerald Virtual Global
Healthcare Conference has been rescheduled to today, September 30,
2021 at 12:40 PM eastern time.
Details for the company’s presentation are as
follows:
Cantor Fitzgerald Virtual Global Healthcare
Conference:Date: Thursday, September 30,
2021Rescheduled Time: 12:40 pm EDTInvestors can
register for the conference HERE.
Following the conference a webcast replay of the
presentation will be available on the Investor section of the
company’s website, www.electrocore.com.
About electroCore,
Inc.electroCore, Inc. is a commercial stage bioelectronic
medicine company dedicated to improving patient outcomes through
its non-invasive vagus nerve stimulation therapy platform,
initially focused on the treatment of multiple conditions in
neurology. The company's current indications are the preventive
treatment of cluster headache and migraine and the acute treatment
of migraine and episodic cluster headache.For more information,
visit www.electrocore.com.
Investors:
Rich Cockrell
CG Capital
404-736-3838
ecor@cg.capital
or
Media Contact:
Jackie Dorsky
electroCore
908-313-6331
Jackie.dorsky@electrocore.com
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024